Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4 participants
INTERVENTIONAL
2013-07-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Hormone Response After Paleolithic-type Meals
NCT01999504
Glycemic Response After Palaeolithic-type Meals
NCT01418573
Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model
NCT05977244
Determinants and Outcomes of High vs. Low Ultra-processed Feeding
NCT06310603
The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge
NCT02655367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The recruitment of participants will be carried out by Alan Mackie at the Institute of Food Research in Norwich. Four apparently healthy participants will be recruited onto the study. Apparently healthy male participants with BMI between 19 and 35 will be recruited either by advertisement or identified from the Institute of Food Research (IFR) Human Nutrition Unit (HNU) Volunteer Database.
Preliminary telephone interview with Alan Mackie, the chief investigator will establish inclusion/exclusion criteria of potential participants who respond to the advertisement and/or the invitation letter. Potential participants will be invited to attend an interview at the HNU at IFR to meet the chief investigator to discuss the study protocol, test meals and to ask any question they have about the study. They will then have a minimum of 72 hours to consider their participation. They will be asked to contact the chief investigator if they are still interested and they will not be contacted by anyone from the research team during this time.
After the participant's response, a next visit will be arranged at the IFR HNU to obtain written consent (Annex 4) and complete an MRI safety questionnaire (Annex 10). The consent will be taken by the Chief Investigator or Senior Research Nurse. Participants consent is a requirement of the screening procedure, during which weight, height and blood pressure will be assessed. Enrollment is contingent on a screening questionnaire (Annex 5) and simple screening (urine dipstick), carried out by the HNU research nurse.
If a participant decides to join the study, the appointment will be made for their Study Test Day at the Radiology Department at the NNUHFT.
On each study day participants will be asked to eat their breakfast at home (before 09:00). The breakfast meal should be recorded (Annex 6) so that it can be repeated on the second visit. They may drink water as much as they need but only until 10am. They will subsequently not be allowed any food or drink.
The study involves participants attending the Radiology Department at the NNUHFT on two separate occasions to consume a test meal (allocated at random)and undergoing 11 MRI scans of the abdomen on each of the two test days.
On each day, after initial formalities, including checking the MRI patient safety questionnaire and changing into a surgical gown, each participant will undergo the first MRI scan (baseline measurement) and complete a VAS questionnaire. If the baseline scan shows significant content as a result of consumption of food after 09:00 then the participant will be rescheduled. The participant will then be asked to consume the meal, allocated at random. The meal will be plated out and consumed in an appropriate room adjacent to the MRI facility. Immediately after the meal has been consumed the second MRI scan will be performed with subsequent scans being undertaken as laid out in the protocol. For each measurement the participant will lie on the scanner table positioned beneath the torsophased array surface coil placed over the upper abdomen. A breath hold scan will be performed to determine stomach position before the full imaging session. Each scanning session takes approximately 5 minutes, in between scans the participant will sit just outside the scanner room. The participants will be asked to repeatedly complete a VAS satiety questionnaire. The timing of these will be predetermined and is given in the protocol.
There will be 1 more study day, similar to Day 1, carried out at least 7 days apart with a different test meal on each occasion (in random order).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ref meal
The reference meal (REF) is based on WHO dietary guidelines for protein, fat and carbohydrate. It comprises everyday "modern" ingredients such as white rice.
REF meal
The effect of consuming the REF meal on gastric retention will be assessed
PAL meal
Palaeolithic meal (PAL) is based on WHO dietary guidelines for protein, fat and carbohydrate but only uses ingredients that would have been available in Palaeolithic times (e.g. no cereals or dairy).
PAL meal
The effect of consuming the PAL meal on gastric retention will be assessed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PAL meal
The effect of consuming the PAL meal on gastric retention will be assessed
REF meal
The effect of consuming the REF meal on gastric retention will be assessed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Individuals with an intense dislike of or intolerance / allergy to any of the constituents of the test meal
* Smokers or smoked within the last year (smoking affects satiety/hunger)
* Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease
* Have had surgery on the stomach or intestine or suffered from oesophageal or gastrointestinal disease, whether diagnosed or self-reported
* Regular (more than once in 10 days) use of antacids, laxatives
* Any problems with swallowing
* Take medication for digestive or gastrointestinal conditions.
* Participants taking part in another study (other than a questionnaire based study).
* Blood pressure greater than 160/100 mmHg or less than 90/50 or 95/55 mmHg if symptomatic.
* Individuals with special dietary requirements (eg vegetarians)
* If any of the clinical screening results are indicative of a health problem which would affect the participants well-being or which would affect the study data.
* Refusal to give permission to inform GP of participation in study
* Recent unexplained weight gain or loss
* History of back problems or any other condition which limit ability to repeatedly sit up and lie down
* Hiatus Hernia
* Cardiac pacemaker or artificial heart valve
* Any surgery in the last 6 months
* Aneurysm clips (metal clips from surgery)
* Implant, pump or any medical device in the body (eg cochlear implant, neurostimulator, intra-venticular shunt)
* Worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings
* Have artificial eyes or limbs
* Have been injured with shrapnel or bullets
* Have a metal tattoo
* Suffer from fits, blackouts or epilepsy
* Claustrophobia sufferer
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
OTHER
Unilever R&D
INDUSTRY
Quadram Institute Bioscience
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan R Mackie, PhD
Role: PRINCIPAL_INVESTIGATOR
Quadram Institute Bioscience
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Food Research
Norwich, Norfolk, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IFR02/2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.